Search - tctmd.com

Displaying 801 - 820 of 1267

Sort: Relevancy | Date

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2020

Shelley Wood

July 31, 2020

News Daily News

Signs of Cardiac Damage Even in Younger, Nonhospitalized COVID-19 Patients

Shelley Wood

July 29, 2020

News Features

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Shelley Wood

July 20, 2020

News Daily News

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Michael O'Riordan

July 16, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2020

Shelley Wood

July 02, 2020

News Daily News

CMS Releases Proposed Updates for Coverage of Transcatheter MV Repair

Todd Neale

July 01, 2020

News Daily News

Too Many HF Trial Results Underreported or Never Published

L.A. McKeown

June 23, 2020

News Conference News TVT 2020

MitraClip Cuts Death, HF Hospitalization Across NYHA Class: COAPT

Michael O'Riordan

June 21, 2020

News Daily News

VA Efforts to Cut HF Readmissions are Working, With No Uptick in Deaths

L.A. McKeown

June 18, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2020

Shelley Wood

June 04, 2020

News Daily News

Even Very Sick Kids Fare Well Despite Kawasaki-Like COVID-19 Symptoms

Todd Neale

May 21, 2020

News Daily News

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

Yael L. Maxwell

May 21, 2020

News Conference News HRS 2020

Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’

Michael O'Riordan

May 21, 2020

News Daily News

Latest Kawasaki Series Offers Clues to COVID-19 in Kids as Debate Persists

Shelley Wood

May 14, 2020

News Conference News HRS 2020

Subcutaneous ICD Holds Up Well Against Transvenous Devices

Todd Neale

May 13, 2020

News Daily News

Mavacamten Successful in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM

Shelley Wood

May 11, 2020

News Daily News

FDA Clears Dapagliflozin for Heart Failure With Reduced Ejection Fraction

Shelley Wood

May 06, 2020

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2020

Shelley Wood

May 01, 2020

Advertisement

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

TCTMD’s Top 10 Most Popular Stories for July 2020

Signs of Cardiac Damage Even in Younger, Nonhospitalized COVID-19 Patients

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Higher Risk of HF After ACS for Women Previously on Beta-blockers

TCTMD’s Top 10 Most Popular Stories for June 2020

CMS Releases Proposed Updates for Coverage of Transcatheter MV Repair

Too Many HF Trial Results Underreported or Never Published

MitraClip Cuts Death, HF Hospitalization Across NYHA Class: COAPT

VA Efforts to Cut HF Readmissions are Working, With No Uptick in Deaths

TCTMD’s Top 10 Most Popular Stories for May 2020

Even Very Sick Kids Fare Well Despite Kawasaki-Like COVID-19 Symptoms

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’

Latest Kawasaki Series Offers Clues to COVID-19 in Kids as Debate Persists

Subcutaneous ICD Holds Up Well Against Transvenous Devices

Mavacamten Successful in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM

FDA Clears Dapagliflozin for Heart Failure With Reduced Ejection Fraction

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

TCTMD’s Top 10 Most Popular Stories for April 2020

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content